Summary
HCA Holdings, Inc. reported its first quarter 2014 financial results, showing a slight increase in net income attributable to HCA Holdings, Inc. to $347 million ($0.76 per diluted share) from $344 million ($0.74 per diluted share) in the prior year's quarter. Total revenues grew by 4.6% to $8.832 billion. The company experienced revenue growth driven by an increase in revenue per equivalent admission, despite a slight decrease in equivalent admissions. Operational highlights include a notable increase in the provision for doubtful accounts and associated uninsured discounts, indicating pressure from patients with less insurance coverage. The company also recorded significant legal claim costs related to the Health Midwest litigation. Financially, HCA managed its debt by issuing new notes and repaying existing ones, demonstrating active capital management. The company maintains a strong liquidity position with substantial credit facilities available. However, the company faces ongoing legal and regulatory scrutiny, including investigations into billing practices and a recent adverse ruling in the UK regarding competition in the private healthcare market, for which an appeal is planned. Investors should monitor the impact of healthcare reform, evolving reimbursement policies, and the resolution of ongoing legal matters.
Financial Highlights
44 data points| Revenue | $8.83B |
| Interest Expense | $460.00M |
| Net Income | $347.00M |
| EPS (Basic) | $0.78 |
| EPS (Diluted) | $0.76 |
| Shares Outstanding (Basic) | 442.15M |
| Shares Outstanding (Diluted) | 457.45M |
Key Highlights
- 1Net income attributable to HCA Holdings, Inc. increased slightly to $347 million from $344 million in Q1 2013, with diluted EPS at $0.76 versus $0.74.
- 2Total revenues grew by 4.6% to $8.832 billion, driven by a 3.9% increase in revenue per equivalent admission.
- 3The provision for doubtful accounts significantly increased by $97 million year-over-year, reflecting challenges with uninsured patients and higher uninsured discounts.
- 4The company recorded $78 million in legal claim costs related to the Health Midwest litigation, impacting profitability.
- 5HCA actively managed its debt during the quarter, issuing $3.5 billion in new notes and repaying $500 million in existing senior unsecured notes.
- 6Liquidity remains strong, with $4.442 billion available under senior secured credit facilities as of March 31, 2014.
- 7The company is subject to ongoing government investigations and litigation, including a recent ruling by the UK Competition and Markets Authority requiring divestiture of certain London hospitals.